Loading organizations...
Xoloninvest operates as a private equity firm, specializing in financial services for new technology businesses based in South Korea. The firm provides capital to early-stage companies and engages in both listed and unlisted mezzanine investments, alongside pre-IPO financing. Their approach supports emerging ventures through various growth phases, acting as a financial catalyst.
Established in 2015, Xoloninvest was founded by a team of experienced professionals in South Korea, identifying a critical need for tailored capital solutions within the rapidly expanding technology sector. This foundational insight drove the creation of a firm dedicated to structuring investments that bridge funding gaps for innovative companies, particularly before their public market debut.
Xoloninvest primarily serves a diverse clientele of growing businesses, ranging from nascent startups seeking initial capital to more mature companies pursuing strategic pre-IPO funding. The firm’s long-term vision centers on cultivating the South Korean innovation landscape by strategically deploying capital into promising ventures, thereby contributing to the development of future market leaders.
Xoloninvest has 3 tracked investments across 3 companies. The latest tracked deal is $15.1M Series C in NEUROPHET in November 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 13, 2023 | NEUROPHET | $15.1M Series C | — | DB Financial Investment, Industrial Bank OF Korea, KB Investment, Kolon Investment, Mirae Asset Securities, Profit Asset Management, Quad Investment Management, Seoil E&M, Solidus Investment |
| Jun 10, 2021 | Ringle | $17.9M Series A | Must Asset Management | Moca Ventures, ONE Asset Management |
| Nov 19, 2020 | Rebus Biosystems | $20.0M Series B | TOM Willis | CTK Investments, Labgenomics, Lifecore Partners, NCORE Ventures, RAY, Seegene Medical Foundation, Timefolio Asset Management |